Controlled Substances
Critical APIs and intermediates with unstable pipelines and recurring shortage risk in North America, secured through
Our High-Potency API (HPAPI) product range includes specialized pharmaceutical compounds used across oncology, targeted therapies, highly potent hormone and steroid applications, and immunosuppressive drug development.
These compounds require controlled handling, appropriate containment, and comprehensive technical documentation. Our HPAPI offering is designed to support pharmaceutical manufacturers, CDMOs, formulation developers, and sourcing teams with access to specialized active pharmaceutical ingredients.
| Compound | Category | OEL (MG/M³) |
Polymorphic Forms | Documentation |
|---|---|---|---|---|
|
Paclitaxel
CAS: 33069–62–4
|
Cytotoxic | < 0.001 mg/m³ |
Form I
Form II
|
CoA
DMF
MSDS
GIP
|
|
Cisplatin
CAS: 15663–27–1
|
Cytotoxic | < 0.002 mg/m³ | — |
CoA
DMF
MSDS
GIP
|
|
Docetaxel
CAS: 114977–28–5
|
Cytotoxic — Taxane | < 0.001 mg/m³ |
Anhydrous
Trihydrate
|
CoA
DMF
MSDS
GIP
|
|
Imatinib Mesylate
CAS: 220127–57–1
|
Kinase Inhibitor | < 0.1 mg/m³ |
Form α
Form β
|
CoA
DMF
MSDS
|
|
Erlotinib HCl
CAS: 183319–69–9
|
EGFR Kinase Inhibitor | < 0.1 mg/m³ |
Form A
|
CoA
DMF
MSDS
|
Sourcing high-potency active pharmaceutical ingredients requires careful consideration of potency, occupational exposure limits, material specifications, polymorphic forms, documentation, and manufacturing requirements.
Our HPAPI product range provides pharmaceutical and biotechnology organizations with access to specialized compounds for development and manufacturing programs while supporting documentation and sourcing requirements.